Sosei Group Corporation is a holding company which was established through reorganization.  The Group companies are biopharmaceutical companies specializing in drug development.  Sosei Group enters into license agreements primarily with US, EU, and Japanese companies to market the licensed drugs in Japan and find alternative usage on such drugs.

Notice Of Issuance Of New Shares Under Rsu Plan And Determination Of Pmt Amount And Other Matters Of Issuance Of New Shares Under Previous Years’ Rsu

Nxera Pharma’S Partner Tempero Bio Initiates Phase 2 Trial With Tmp-301 For Alcohol Use Disorder

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00